ON DEMAND webinar: What the future holds for advanced NSCLC patients with resistance to EGFR TKIs

Learning objective:         

After watching this broadcast, participants should be able to:

• Discuss the unmet needs for advanced NSCLC patients with EGFR Exon20 insertion mutations
• Discuss the latest data on novel treatments in this patient group
• Understand the novel management paradigms for TKI resistant disease in advanced NSCLC patients with EGFR mutations

Faculty:

• Tetsuya Mitsudomi (Japan)
• Enriqueta Felip (Spain)
• Byoung Chul Cho (South Korea)